Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HLA-DR anticorps

L’anticorps anti-HLA-DR Monoclonal Souris est utilisé pour la détection de HLA-DR dans des échantillons de Humain. Il a été validé pour FACS et IF.
N° du produit ABIN3026340
642,40 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour HLA-DR anticorps (ABIN3026340)

Antigène

HLA-DR

Reactivité

  • 179
  • 22
  • 19
  • 18
  • 18
  • 13
  • 11
  • 8
  • 6
  • 4
  • 2
  • 2
Humain

Hôte

  • 136
  • 36
  • 10
  • 3
Souris

Clonalité

  • 177
  • 6
  • 1
Monoclonal

Conjugué

  • 79
  • 18
  • 17
  • 11
  • 9
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp HLA-DR est non-conjugé

Application

  • 127
  • 53
  • 49
  • 26
  • 24
  • 17
  • 12
  • 10
  • 10
  • 10
  • 9
  • 6
  • 5
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF)

Classe de qualité

Carrier-free

Clone

169-1B5-2
  • Fonction

    HLA-DR Antibody (MHC II) (azide and preservative free)

    Attributs du produit

    This antibody detects a monomorphic general framework determinant of HLA-DR Class II antigen. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kDa alpha (heavy) chain and a 28 kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 Molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.

    Purification

    Protein G affinity chromatography

    Immunogène

    Human peripheral blood leukocytes were used as the immunogen for the HLA-DR antibody.

    Isotype

    IgG2b, kappa
  • Indications d'application

    Optimal dilution of the HLA-DR antibody should be determined by the researcher.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    Agent conservateur

    Azide free

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store the HLA-DR antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
  • Antigène

    HLA-DR

    Autre désignation

    HLA-DR

    Sujet

    This antibody detects a monomorphic general framework determinant of HLA-DR Class II antigen. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kDa alpha (heavy) chain and a 28 kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 Molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.

    UniProt

    P01903

    Pathways

    Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Vous êtes ici:
Chat with us!